NCT03927677View on ClinicalTrials.gov

The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 5, 2019

Primary Completion Date

November 26, 2019

Study Completion Date

November 26, 2019

Conditions

GoutHyperuricemia

Interventions

DRUG

Xanthine Oxidase Inhibitor

LC350189 200mg qd

Trial Locations (1)

78744

PPD, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LG Chem

INDUSTRY

NCT03927677 - The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults. | Biotech Hunter | Biotech Hunter